Vanta Bioscience

{
  "main_header": {
    "sid": 1002854,
    "name": "Vanta Bioscience",
    "stock_name": "Vanta Bioscience",
    "full_name": "Vanta Bioscience Ltd",
    "name_url": "stocks-analysis/vanta-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.60",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "20.60",
    "mcapval": "11.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540729,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE695X01011",
    "curr_date": "Mar 04",
    "curr_time": "",
    "bse_nse_vol": "3.0 k",
    "exc_status": "Active",
    "traded_date": "Mar 04, 2026",
    "traded_date_str": "2026 03 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vanta-bioscience-1002854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 17,
    "sid": "1002854",
    "stock_news_url": "https://www.marketsmojo.com/news/vanta-bioscience-1002854"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Vanta Bioscience Ltd",
      "datetime": "25-Feb-2026",
      "details": "The Exchange has sought clarification from Vanta Bioscience Ltd on February 25 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Appointment Of Company Secretary And Compliance Officer",
      "datetime": "30-Jan-2026",
      "details": "Outcome of the Board Meeting - Appointment of Company Secretary and Compliance Officer",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Half Year Ended September 30 2025",
      "datetime": "14-Nov-2025",
      "details": "Financial results for the half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News